2Deparment of Family Medicine, İstanbul Training and Research Hospital, İstanbul-Türkiye
3Deparment of Radiation Oncology, Istanbul Oncology Hospital, İstanbul-Türkiye DOI : 10.5505/tjo.2022.3665 OBJECTIVE
In our study, it was aimed to compare the anxiety; state and trait anxiety states among the communities who went to health institutions for different purposes during the COVID-19 epidemic and to evaluate the factors affecting anxiety, state and trait anxiety.
METHODS
The data of this study were collected face to face using the Beck Anxiety Inventory (BAI), State Anxiety
Inventory (STAI-S) and Trait Anxiety Inventory (STAI-T) for cancer patients who applied to the Oncology
center between October 2020 and December 2020. Their companions and the patients who went to
a primary healthcare institution. Participants" awareness of the COVID pandemic and the effects of the
pandemic on their lives and demographic information were also recorded. A total of 252 participants
responded to the tests.
RESULTS
In our study, 252 people, including 130 (51.6%) cancer patients, 49 (19.4%) cancer patient companions,
and 73 outpatients who applied to a primary healthcare institution, participated in our study. In all
participants, the mean anxiety level according to BAI was 10.75±12.5 (0?48), the mean state anxiety
according to STAI-S was 44.42±10.59 (20?74), according to STAI-T, the mean trait anxiety was found to
be 45.65±8.80 (20?78) points. Among the three groups, the highest anxiety, state and trait anxiety was
seen in patients who applied to primary healthcare institution.
CONCLUSION
In our study, many factors affecting the anxiety and anxiety levels of the patients and their relatives
who applied to health institutions for different reasons, also under the influence of the pandemic, were
determined. With such studies, the psychosocial conditions of the patients and their relatives should be
closely followed in the event of the future epidemics, and psychological treatments and support needs
should be kept in mind in addition to the primary treatment of their diseases.